The USA and Europe reached an agreement yesterday on import duties, but the details are still being worked out. However, the ...

The German Federal Joint Committee (G-BA) has commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to ...

Denmark’s pharmaceutical industry body has warned that a new European health data regulation could hamper medical innovation ...

The 39% tariffs imposed by the USA threaten Switzerland with enormous economic damage. Even though pharmaceutical products are exempt from tariffs for the time being, with the latest decision on "Most ...

Among last week’s news, US biotech Celcuity leapt 180% on new Phase III data for its cancer drug candidate gedatolisib. US drugmaker Madrigal Pharmaceuticals entered into a licensing deal with China’s ...

The US Food and Drug Administration (FDA) approved San Diego, USA-based LENZ Therapeutics’ VIZZ (aceclidine ophthalmic ...

After nearly 27 years as a division of Swiss giant Novartis, generics and biosimilars specialist Sandoz (SWX: SDZ) went its ...

England has agreed to commission the use of Hemlibra (emicizumab) as a prophylactic treatment for patients of all ages with ...

Swiss pharma giant Roche announced positive five-year efficacy, safety and durability data from the Phase III Portal study, a ...

German healthcare and crop sciences giant Bayer (BAYN DE) saw its share close up 2.8% at 28.12 euros, after it provided an ...

For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation ...

Frazier Life Sciences (FLS), a US investment firm focused on innovative therapeutics, has announced the closing of its ...